China Botanic Pharma (CBP) Posts Stronger Q1 Results; Reaffirms Outlook
Tweet Send to a FriendGet Alerts CBP Hot Sheet
Trade CBP Now!
China Botanic Pharmaceutical Inc. (NYSE: CBP) reported Q1 EPS of $0.29, versus $0.20 last year. Revenue for the quarter came in at $22.6 million, versus $17.1 million last year.
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Reaffirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Korn/Ferry Int'l (KFY) Tops Q4 EPS by 1c, Offers Q1 Guidance
- GenMark Diagnostics (GNMK) Warns for FY2013
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
